Kingsley Wheaton: A Year Ago, Omni Was an Idea – Today, It’s a Movement!
Kingsley Wheaton, Chief Corporate Officer at BAT, shared on LinkedIn:
”A year ago, Omni™ was an idea. Today, it’s a movement.
I had the privilege of sharing our journey at the Global Tobacco and Nicotine Forum (GTNF) in Brussels, and I’d like to offer you a glimpse of that moment through a short video summary of my remarks.
Our vision for a Smokeless World rests on scientific rigor and transformative leadership.
For 15 years, we’ve remained steadfast, meeting doubts with evidence, challenges with innovation, and change with conviction.
This is more than communication; it is clarity with purpose and progress that endures.
If you’re curious about where science and leadership intersect, I invite you to watch the video below.
Let’s continue to push boundaries, one thoughtful conversation at a time.
Review the evidence.
Join the conversation.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis